| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |